Dr. Sarah Larson is interested in identifying novel signal pathways and therapeutics for B cell lymphomas and multiple myeloma. She works with the lymphoma and multiple myeloma cell line panels in the Translational Oncology Research Laboratory (TORL) and conducts clinical trials as a member of the Hematologic Malignancies Program and the Lymphoma Program.